High-bleeding risk PCI patients enrolled in ongoing clinical trials

Chairpersons: R. Mehran, P. Urban

Speakers: R. Byrne, R. Mehran, J.F. Tanguay, P. Urban, M. Valgimigli, S. Windecker

Summary

Consult this session to learn all about high-bleeding risk PCI patients: how to identify them, how to successfully adapt PCI technique and how to select the optimal antiplatelet treatment post-PCI according to the patient's bleeding and thrombotic risks.

Learning Objectives

To better identify high-bleeding risk patients
To successfully adapt PCI technique and strategies to this group of patients
To select the optimal antiplatelet treatment post-PCI according to the patient\'s bleeding and thrombotic risks

Presentations available when logged in:

Session objectives
Case 1 - Cancer and planned surgery
Review of available data
Case 2 - History of gastrointestinal bleed and on OAC for chronic atrial fibrillation
Review of available data
Case 3 - Moderate baseline anaemia (10-11 g/L)
Review of available data
Case 4 - Elderly patients with only age and prior minor stroke as high-bleeding risk criteria
Review of available data
Session evaluation and key learnings

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

High-bleeding risk PCI patients enrolled in ongoing clinical trials

Learning Objectives

Log in or create account for free